Publications

Authors:

Bassetti, M.; Peghin, M.; Carnelutti, A.; Righi, E.

Title:

How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?

Year:

2017

Type of item:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Language:

Inglese

Referee:

No

Name of journal:

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

ISSN of journal:

1069-3424

N° Volume:

38

Number or Folder:

3

:

Thieme Medical Publishers Incorporated:333 Seventh Avenue:New York, NY 10001:(800)782-3488, (212)760-0888, EMAIL: custserv@thieme.com, INTERNET: http://www.thieme.com, Fax: (212)947-0108

Page numbers:

301-310

Keyword:

hospital-acquired pneumonia; ventilator-acquired pneumonia; carbapenemase-producing Enterobacteriaceae; antibiotic therapy; multidrug-resistant gram negative

Short description of contents:

Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) represent a common problem in hospital setting worldwide. Infections caused by carbapenem-resistant Enterobacteriaceae (CRE) are an emergent problem due to the lack of therapeutic options available, leading to significant increases in morbidity and mortality. CRE have frequently been reported both in HAP/VAP, but limited data regarding the optimal treatment strategy in this setting are available. This review focuses on the current epidemiology of CRE, with a specific focus on HAP/VAP. Moreover, we will suggest a possible strategy for the empiric and targeted treatment of HAP and VAP in which the involvement of CRE is suspected or is confirmed.

Product ID:

126955

Handle IRIS:

11562/1065336

Last Modified:

March 28, 2023

Bibliographic citation:

Bassetti, M.; Peghin, M.; Carnelutti, A.; Righi, E., How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae? «SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE» , vol. 38 , n. 3 , 2017 , pp. 301-310

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo